Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NXDT
13101
CALL
NexPoint Diversified Real Estate Trust
NXDT
$271M
| $21.4K | ﹤0.01% |
3,500
-1,200
| -26% | -$7.04K |
|
13102
PUT
China Automotive Systems
CAAS
$142M
| $21.3K | ﹤0.01% |
5,200
+4,200
| +420% | +$18.4K |
|
13103
PUT
Angi Inc
ANGI
$191M
| $21.2K | ﹤0.01% |
1,280
-900
| -41% | -$19.2K |
|
13104
AC Immune
ACIU
$248M
| $21.2K | ﹤0.01% |
7,863
-13,943
| -64% | -$43.6K |
|
13105
PUT
LG Display
LPL
$3.5B
| $21.2K | ﹤0.01% |
6,900
+1,300
| +23% | +$4.58K |
|
13106
CALL
YieldMax Magnificent 7 Fund of Option Income ETFs
YMAG
$287M
| $21.2K | ﹤0.01% |
1,100
-4,900
| -82% | -$95.1K |
|
13107
PUT
Alerus Financial
ALRS
$838M
| $21.2K | ﹤0.01% |
+1,100
| New | +$24.2K |
|
13108
PUT
Transcat
TRNS
$877M
| $21.1K | ﹤0.01% |
200
-500
| -71% | -$55.5K |
|
|
SHYF
13109
CALL
DELISTED
The Shyft Group
SHYF
| $21.1K | ﹤0.01% |
1,800
+1,000
| +125% | +$12.9K |
|
13110
Euro Tech Holdings
CLWT
$12.5M
| $21.1K | ﹤0.01% |
15,179
-3,731
| -20% | -$5.59K |
|
13111
PUT
Lantronix
LTRX
$289M
| $21K | ﹤0.01% |
5,100
+1,500
| +42% | +$5.36K |
|
|
KYNB
13112
PUT
Kyntra Bio
KYNB
$28.5M
| $21K | ﹤0.01% |
1,584
+204
| +15% | +$1.9K |
|
13113
CALL
Luxfer Holdings
LXFR
$457M
| $20.9K | ﹤0.01% |
1,600
-2,800
| -64% | -$38.3K |
|
13114
CALL
Lloyds Banking Group
LYG
$90.1B
| $20.9K | ﹤0.01% |
7,700
+200
| +3% | +$571 |
|
13115
PUT
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.2B
| $20.9K | ﹤0.01% |
+800
| New | +$21.8K |
|
13116
CALL
Townsquare Media
TSQ
$104M
| $20.9K | ﹤0.01% |
2,300
-11,200
| -83% | -$112K |
|
13117
PUT
Zentalis Pharmaceuticals
ZNTL
$255M
| $20.9K | ﹤0.01% |
6,900
-49,700
| -88% | -$163K |
|
13118
PetMed Express
PETS
$39.5M
| $20.9K | ﹤0.01% |
4,335
+2,034
| +88% | +$9.53K |
|
13119
Nephros
NEPH
$50.3M
| $20.9K | ﹤0.01% |
14,289
-2,947
| -17% | -$4.49K |
|
13120
CALL
Siebert Financial
SIEB
$78.9M
| $20.9K | ﹤0.01% |
6,600
-1,500
| -19% | -$4.07K |
|
13121
PUT
loanDepot
LDI
$303M
| $20.8K | ﹤0.01% |
10,200
-4,500
| -31% | -$10K |
|
|
STKL
13122
PUT
DELISTED
SunOpta
STKL
| $20.8K | ﹤0.01% |
2,700
+500
| +23% | +$3.54K |
|
13123
PUT
ACI Worldwide
ACIW
$5.4B
| $20.8K | ﹤0.01% |
400
-2,600
| -87% | -$138K |
|
13124
PUT
First Hawaiian
FHB
$3.37B
| $20.8K | ﹤0.01% |
800
-1,000
| -56% | -$25.7K |
|
13125
Zevra Therapeutics
ZVRA
$672M
| $20.8K | ﹤0.01% |
2,489
-65,420
| -96% | -$558K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.